Jounce Therapeutics, Inc.

Erste Asset Management GmbH

Report date

3/31/2023

Quarter

2023 Q1

Filed

11/26/2024

Shares

1,559,587

Value ($000)

2,885

Weight

0.1%

2018 Q4 - 2023 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	11/26/2024	2,885	0.1%	1,559,587	3/31/2023
2022 Q4	11/26/2024	1,621	0.0%	1,459,587	12/31/2022
2022 Q3	11/26/2024	1,981	0.0%	849,587	9/30/2022
2022 Q2	11/26/2024	2,575	0.1%	849,587	6/30/2022
2022 Q1	11/25/2024	5,226	0.1%	769,587	3/31/2022
2021 Q4	11/25/2024	5,920	0.1%	729,587	12/31/2021
2021 Q3	11/25/2024	5,787	0.1%	779,587	9/30/2021
2021 Q2	11/25/2024	4,474	0.1%	659,587	6/30/2021
2021 Q1	11/25/2024	6,492	0.2%	634,587	3/31/2021
2020 Q4	11/25/2024	3,899	0.1%	584,587	12/31/2020
2020 Q3	11/25/2024	4,770	0.2%	584,587	9/30/2020
2020 Q2	11/22/2024	3,827	0.2%	554,587	6/30/2020
2020 Q1	11/22/2024	2,872	0.2%	604,587	3/31/2020
2019 Q4	11/22/2024	5,472	0.2%	672,687	12/31/2019
2019 Q3	11/22/2024	2,111	0.1%	632,687	9/30/2019
2019 Q2	11/22/2024	2,996	0.2%	607,687	6/30/2019
2019 Q1	11/22/2024	3,524	0.2%	568,687	3/31/2019
2018 Q4	11/26/2024	1,035	0.1%	310,100	12/31/2018